CENCORA INC (ABG.DE) Stock Fundamental Analysis

FRA:ABG • US03073E1055

301.7 EUR
+17.7 (+6.23%)
Last: Feb 10, 2026, 07:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ABG. ABG was compared to 29 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of ABG get a neutral evaluation. Nothing too spectacular is happening here. While showing a medium growth rate, ABG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ABG had positive earnings in the past year.
  • ABG had a positive operating cash flow in the past year.
  • ABG had positive earnings in each of the past 5 years.
  • ABG had a positive operating cash flow in each of the past 5 years.
ABG.DE Yearly Net Income VS EBIT VS OCF VS FCFABG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B

1.2 Ratios

  • With a Return On Assets value of 2.07%, ABG perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 85.16%, ABG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • The Return On Invested Capital of ABG (14.99%) is better than 96.55% of its industry peers.
  • ABG had an Average Return On Invested Capital over the past 3 years of 15.04%. This is significantly above the industry average of 6.14%.
Industry RankSector Rank
ROA 2.07%
ROE 85.16%
ROIC 14.99%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ABG.DE Yearly ROA, ROE, ROICABG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • ABG has a Profit Margin of 0.50%. This is in the lower half of the industry: ABG underperforms 65.52% of its industry peers.
  • ABG's Profit Margin has declined in the last couple of years.
  • The Operating Margin of ABG (1.22%) is worse than 86.21% of its industry peers.
  • ABG's Operating Margin has improved in the last couple of years.
  • The Gross Margin of ABG (3.63%) is worse than 72.41% of its industry peers.
  • ABG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.22%
PM (TTM) 0.5%
GM 3.63%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
ABG.DE Yearly Profit, Operating, Gross MarginsABG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 3

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ABG is creating value.
  • Compared to 1 year ago, ABG has less shares outstanding
  • Compared to 5 years ago, ABG has less shares outstanding
  • The debt/assets ratio for ABG is higher compared to a year ago.
ABG.DE Yearly Shares OutstandingABG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ABG.DE Yearly Total Debt VS Total AssetsABG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • ABG has an Altman-Z score of 4.92. This indicates that ABG is financially healthy and has little risk of bankruptcy at the moment.
  • ABG's Altman-Z score of 4.92 is amongst the best of the industry. ABG outperforms 93.10% of its industry peers.
  • ABG has a debt to FCF ratio of 2.20. This is a good value and a sign of high solvency as ABG would need 2.20 years to pay back of all of its debts.
  • ABG's Debt to FCF ratio of 2.20 is amongst the best of the industry. ABG outperforms 93.10% of its industry peers.
  • ABG has a Debt/Equity ratio of 3.97. This is a high value indicating a heavy dependency on external financing.
  • ABG has a worse Debt to Equity ratio (3.97) than 79.31% of its industry peers.
  • Although ABG does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF 2.2
Altman-Z 4.92
ROIC/WACC1.8
WACC8.32%
ABG.DE Yearly LT Debt VS Equity VS FCFABG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • ABG has a Current Ratio of 0.92. This is a bad value and indicates that ABG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ABG has a Current ratio of 0.92. This is comparable to the rest of the industry: ABG outperforms 51.72% of its industry peers.
  • A Quick Ratio of 0.51 indicates that ABG may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.51, ABG is not doing good in the industry: 72.41% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.51
ABG.DE Yearly Current Assets VS Current LiabilitesABG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

  • ABG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.99%, which is quite good.
  • ABG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.14% yearly.
  • The Revenue has been growing slightly by 7.45% in the past year.
  • The Revenue has been growing by 11.09% on average over the past years. This is quite good.
EPS 1Y (TTM)14.99%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%9.38%
Revenue 1Y (TTM)7.45%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.42%

3.2 Future

  • Based on estimates for the next years, ABG will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.77% on average per year.
  • The Revenue is expected to grow by 7.10% on average over the next years.
EPS Next Y11.24%
EPS Next 2Y10.62%
EPS Next 3Y10.53%
EPS Next 5Y11.77%
Revenue Next Year6.23%
Revenue Next 2Y6.21%
Revenue Next 3Y6.37%
Revenue Next 5Y7.1%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ABG.DE Yearly Revenue VS EstimatesABG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100B 200B 300B 400B
ABG.DE Yearly EPS VS EstimatesABG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

  • ABG is valuated rather expensively with a Price/Earnings ratio of 21.89.
  • ABG's Price/Earnings ratio is in line with the industry average.
  • ABG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.19.
  • The Price/Forward Earnings ratio is 18.28, which indicates a rather expensive current valuation of ABG.
  • 72.41% of the companies in the same industry are cheaper than ABG, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of ABG to the average of the S&P500 Index (28.06), we can say ABG is valued slightly cheaper.
Industry RankSector Rank
PE 21.89
Fwd PE 18.28
ABG.DE Price Earnings VS Forward Price EarningsABG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 72.41% of the companies in the same industry are cheaper than ABG, based on the Enterprise Value to EBITDA ratio.
  • ABG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 19.29
EV/EBITDA 15.08
ABG.DE Per share dataABG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABG does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of ABG may justify a higher PE ratio.
PEG (NY)1.95
PEG (5Y)1.45
EPS Next 2Y10.62%
EPS Next 3Y10.53%

4

5. Dividend

5.1 Amount

  • ABG has a yearly dividend return of 0.68%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.79, ABG is paying slightly less dividend.
  • With a Dividend Yield of 0.68, ABG pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of ABG grows each year by 6.10%, which is quite nice.
Dividend Growth(5Y)6.1%
Div Incr YearsN/A
Div Non Decr YearsN/A
ABG.DE Yearly Dividends per shareABG.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 27.86% of the earnings are spent on dividend by ABG. This is a low number and sustainable payout ratio.
  • The dividend of ABG is growing, but earnings are growing more, so the dividend growth is sustainable.
DP27.86%
EPS Next 2Y10.62%
EPS Next 3Y10.53%
ABG.DE Yearly Income VS Free CF VS DividendABG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B
ABG.DE Dividend Payout.ABG.DE Dividend Payout, showing the Payout Ratio.ABG.DE Dividend Payout.PayoutRetained Earnings

CENCORA INC

FRA:ABG (2/10/2026, 7:00:00 PM)

301.7

+17.7 (+6.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners95.74%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap58.69B
Revenue(TTM)325.78B
Net Income(TTM)1.63B
Analysts82.73
Price Target332.07 (10.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend1.9
Dividend Growth(5Y)6.1%
DP27.86%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.22%
Min EPS beat(2)0.03%
Max EPS beat(2)0.41%
EPS beat(4)4
Avg EPS beat(4)2.55%
Min EPS beat(4)0.03%
Max EPS beat(4)6.6%
EPS beat(8)8
Avg EPS beat(8)2.86%
EPS beat(12)12
Avg EPS beat(12)3.68%
EPS beat(16)16
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-0.9%
Min Revenue beat(2)-1.14%
Max Revenue beat(2)-0.67%
Revenue beat(4)0
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)-0.35%
Revenue beat(8)3
Avg Revenue beat(8)-0.48%
Revenue beat(12)7
Avg Revenue beat(12)0.89%
Revenue beat(16)9
Avg Revenue beat(16)0.65%
PT rev (1m)-0.53%
PT rev (3m)N/A
EPS NQ rev (1m)-0.5%
EPS NQ rev (3m)-0.5%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)0.64%
Revenue NQ rev (1m)2.02%
Revenue NQ rev (3m)2.06%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 21.89
Fwd PE 18.28
P/S 0.21
P/FCF 19.29
P/OCF 16.22
P/B 36.46
P/tB N/A
EV/EBITDA 15.08
EPS(TTM)13.78
EY4.57%
EPS(NY)16.5
Fwd EY5.47%
FCF(TTM)15.64
FCFY5.18%
OCF(TTM)18.6
OCFY6.16%
SpS1412.65
BVpS8.27
TBVpS-67.22
PEG (NY)1.95
PEG (5Y)1.45
Graham Number50.65
Profitability
Industry RankSector Rank
ROA 2.07%
ROE 85.16%
ROCE 20.65%
ROIC 14.99%
ROICexc 16.5%
ROICexgc 4337.71%
OM 1.22%
PM (TTM) 0.5%
GM 3.63%
FCFM 1.11%
ROA(3y)2.36%
ROA(5y)2.55%
ROE(3y)223.66%
ROE(5y)N/A
ROIC(3y)15.04%
ROIC(5y)14.55%
ROICexc(3y)19.39%
ROICexc(5y)18.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.71%
ROCE(5y)20.04%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-3.36%
ROICexc growth 5Y-5.64%
OM growth 3Y-0.12%
OM growth 5Y1.81%
PM growth 3Y-12.1%
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y5.18%
F-Score6
Asset Turnover4.16
Health
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF 2.2
Debt/EBITDA 1.51
Cap/Depr 64.83%
Cap/Sales 0.21%
Interest Coverage 10.04
Cash Conversion 85.41%
Profit Quality 221.96%
Current Ratio 0.92
Quick Ratio 0.51
Altman-Z 4.92
F-Score6
WACC8.32%
ROIC/WACC1.8
Cap/Depr(3y)50.93%
Cap/Depr(5y)61.57%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)200.95%
Profit Quality(5y)175.46%
High Growth Momentum
Growth
EPS 1Y (TTM)14.99%
EPS 3Y13.21%
EPS 5Y15.14%
EPS Q2Q%9.38%
EPS Next Y11.24%
EPS Next 2Y10.62%
EPS Next 3Y10.53%
EPS Next 5Y11.77%
Revenue 1Y (TTM)7.45%
Revenue growth 3Y10.43%
Revenue growth 5Y11.09%
Sales Q2Q%5.42%
Revenue Next Year6.23%
Revenue Next 2Y6.21%
Revenue Next 3Y6.37%
Revenue Next 5Y7.1%
EBIT growth 1Y29.6%
EBIT growth 3Y10.3%
EBIT growth 5Y13.11%
EBIT Next Year23.6%
EBIT Next 3Y13.21%
EBIT Next 5Y12.62%
FCF growth 1Y-0.61%
FCF growth 3Y13.28%
FCF growth 5Y11.79%
OCF growth 1Y4.95%
OCF growth 3Y12.76%
OCF growth 5Y11.92%

CENCORA INC / ABG.DE FAQ

What is the fundamental rating for ABG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ABG.DE.


What is the valuation status for ABG stock?

ChartMill assigns a valuation rating of 2 / 10 to CENCORA INC (ABG.DE). This can be considered as Overvalued.


What is the profitability of ABG stock?

CENCORA INC (ABG.DE) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for ABG stock?

The Price/Earnings (PE) ratio for CENCORA INC (ABG.DE) is 21.89 and the Price/Book (PB) ratio is 36.46.


Is the dividend of CENCORA INC sustainable?

The dividend rating of CENCORA INC (ABG.DE) is 4 / 10 and the dividend payout ratio is 27.86%.